drugset / Trial / NCT05357690

A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

NCT05357690

Phase 2/3 Completed 200 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to test if a nerve block procedure called a stellate ganglion block can help decrease the chance of atrial fibrillation after surgery. Atrial fibrillation is the abnormal, fast beating of the upper chambers of the heart. Stellate ganglion blockade has shown to decrease other types of abnormal heart rhythms as well as decrease the chance of atrial fibrillation.

Timeline

Start
2023-04-19
Primary completion
2026-06-08
Completion
2026-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 10 ml Other

Indications